DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lunesta (Eszopiclone) - Summary

 

-- advertisement --

LUNESTA SUMMARY

LUNESTA™ (eszopiclone) TABLETS
1 mg, 2 mg, 3 mg

LUNESTA (eszopiclone) is a nonbenzodiazepine hypnotic agent that is a pyrrolopyrazine derivative of the cyclopyrrolone class.

LUNESTA is indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies, LUNESTA administered at bedtime decreased sleep latency and improved sleep maintenance.

The clinical trials performed in support of efficacy were up to 6 months in duration. The final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study, at the end of both 2-week studies and at the end of the 6-month study.

LUNESTA NEWS HIGHLIGHTS

Media Articles Related to Lunesta (Eszopiclone)

LUNESTA(R) Study Of Patients With Insomnia And Co-Morbid Generalized Anxiety Disorder (GAD) Published In Archives Of General Psychiatry
Source: Anxiety / Stress News From Medical News Today [2008.05.14]

Novel Treatment Offers Insomnia Sufferers Hope Of Quality Sleep
Source: Sleep / Sleep Disorders / Insomnia News From Medical News Today [2008.05.14]

Discovery That Different Processes Govern Sight, Light Detection Could Point Toward Help For SAD, Insomnia Patients
Source: Sleep / Sleep Disorders / Insomnia News From Medical News Today [2008.04.28]

Persistent Insomnia Leads to Depression in Young Adults
Source: MedicineNet Sleep Aids And Stimulants Specialty [2008.04.03]

The Secret Causes of Insomnia: What Every Woman Should Know About Sleep Problems
Source: MedicineNet Restless Leg Syndrome Specialty [2008.02.20]

more>>

Published Studies Related to Lunesta (Eszopiclone)

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. [2007.08.01]

Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression. [2007.02.15]

Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. [2006.12]

A polysomnography study of eszopiclone in elderly patients with insomnia. [2006.09]

Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. [2006.06.01]

more>>

Clinical Trials Related to Lunesta (Eszopiclone)

Efficacy & Safety of Eszopiclone (Lunesta) in Nursing Home Patients

Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and Zyban

Effect of Eszopiclone on Sleep Disturbance & Pain in Cancer

Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-Site, Placebo-Controlled Study of Eszopiclone

Insomnia and Osteoarthritis Study

more>>

Page last updated: 2008-05-14

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008